This trial compares memantine to usual treatment in treating patients with brain tumors. Memantine may improve cognitive function in children and adolescents receiving brain radiation therapy to treat a primary brain tumor.
0 Primary · 0 Secondary · Reporting Duration: At 12 months post baseline
Experimental Treatment
Non-Treatment Group
162 Total Participants · 2 Treatment Groups
Primary Treatment: Memantine Hydrochloride · Has Placebo Group · Phase 3
Age 4 - 17 · All Participants · 10 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: